Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents

Thrombosis Research

Volumn 119, Issue 3, 2007, Pages 337-342

  Huang, Jingqun ^a   Wang, Siwang ^a   Luo, Xiaoxing ^a   Xie, Yanhua ^a   Shi, Xinyou ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cinnamaldehyde; Coagulation time; Hemorrhage time; Platelet aggregation; Thrombosis formation

Indexed keywords

ACROLEIN; ANIMALS; BLEEDING TIME; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVORING AGENTS; HUMANS; MICE; MICE, INBRED BALB C; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET-RICH PLASMA; PULMONARY EMBOLISM; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; THROMBOSIS;

EID: 33845499282     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.03.001     Document Type: Article

References (32)

1. Sherman D.G., and Hart R.G. Thromboembolism and antithrombotic therapy in cerebrovascular disease. J Am Coll Cardiol 8 (1986) 88B-97B
2. Hjemdahl-Monsen C.E., Lewis H.D., Cairns J., Chesebro J.H., and Fuster V. Role of antithrombotic therapy in unstable angina, myocardial infarction and sudden death. J Am Coll Cardiol 8 (1986) 67B-75B
3. Grande P., Grauholt A.M., and Madsen J.K. Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome. Circulation 81 (1990) (I16-9; I22-3)
4. Trip M.D., Cats V.M., van Capelle F.J., and Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 322 (1990) 1549-1554
5. Genton E., Clagett G.P., and Salzman E.W. Antithrombotic therapy in peripheral vascular disease. Chest 89 (1986) 75S-81S
6. Harada M., and Yano S. Pharmacological studies on Chinese cinammon: II. Effects of cinnamaldehyde on the cardiovascular and digestive systems. Chem Pharm Bull 23 (1975) 941-947
7. Matsuda H., Matsuda R., Fukuda S., Shiomoto H., and Kubo M. Anti-thrombic actions of 70% methanolic extract and cinnamic aldehyde from cinnamomi cortex. Chem Pharm Bull 35 (1987) 1275-1280
8. Takenaga M., Hirai A., Terano T., Tamura Y., Kitagawa H., and Yoshida S. In vitro effect of cinnamic aldehyde, a main component of cinnamomi cortex, on human platelet aggregation and arachidonic acid metabolism. J Pharmacobiodyn 10 (1987) 201-208
9. Imai T., Yasuhara K., Tamura T., Takizawa T., Ueda M., Hirose M., et al. Inhibitory effects of cinnamaldehyde on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung carcinogenesis in rasH2 mice. Cancer Lett 175 (2002) 9-16
10. 2/M phase. Biochem Pharmacol 65 (2003) 1343-1350
11. Chang S.T., Chen P.F., and Chang S.C. Antibacterial activity of leaf essential oils and their constituents from cinnamomum osmophloeum. J Ethnopharmacol 77 (2001) 123-127
12. Friedman M., Henika P.R., and Mandrell R.E. Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica. J Food Prot 65 (2002) 1545-1560
13. Mahmoud A.L. Antifungal action and antiaflatoxigenic properties of some essential oil constituents. Lett Appl Microbiol 19 (1994) 110-113
14. Bang K.H., Lee D.W., Park H.M., and Rhee Y.H. Inhibition of fungal cell wall synthesizing enzymes by trans-cinnamaldehyde. Biosci Biotechnol Biochem 64 (2000) 1061-1063
15. Ohta T., Watanabe K., Moriya M., Shirasu Y., and Kada T. Analysis of the antimutagenic effect of cinnamaldehyde on chemically induced mutagenesis in Escherichia coli. Mol Gen Genet 192 (1983) 309-315
16. Shaughnessy D.T., Setzer R.W., and DeMarini D.M. The antimutagenic effect of vanillin and cinnamaldehyde on spontaneous mutation in salmonella TA104 is due to a reduction in mutations at GC but not AT sites. Mutat Res 480-481 (2001) 55-69
17. Yuan J.H., Dieter M.P., Bucher J.R., and Jameson C.W. Toxicokinetics of cinnamaldehyde in F344 rats. Food Chem Toxicol 30 (1992) 997-1004
18. Yuan J., Bucher J.R., Goehl T.J., Dieter M.P., and Jameson C.W. Quantitation of cinnamaldehyde and cinnamic acid in blood by HPLC. J Anal Toxicol 16 (1992) 359-362
19. Yoneda K., Iwamura R., Kishi H., Mizukami Y., Mogami K., and Kobayashi S. Identification of the active metabolite of ticlopidine from rat in vitro metabolites. Br J Pharmacol 142 (2004) 551-557
20. Kitazato K., Kitazato K.T., Sasaki E., Minamiguchi K., and Nagase H. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation. Thromb Res 112 (2003) 83-91
21. Yang T., Jia M., Mei Q., and Shang P. Effects of Angelica polysaccharide on blood coagulation and platelet aggregation. Zhong Yao Cai 25 (2002) 344-345
22. Hsiao G., Shen M.Y., Lin K.H., Chou C.Y., Tzu N.H., Lin C.H., et al. Inhibitory activity of kinetin on free radical formation of activated platelets in vitro and on thrombus formation in vivo. Eur J Pharmacol 465 (2003) 281-287
23. Umar A., Guerin V., Renard M., Boisseau M., Garreau C., Begaud B., et al. Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo. Thromb Res 110 (2003) 135-140
24. Born G.V.R. Aggregation of blood platelet by adenosine diphosphate and is reversal. Nature 194 (1962) 927-929
25. Taylor M.L., Ilton M.K., Misso N.L., Watkins D.N., Hung J., and Thompson P.J. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils. Br J Clin Pharmacol 46 (1998) 139-145
26. Plow E.F., and Ginsberg M.H. Cellular adhesion: GPIIb-IIIa as a prototypic adhesion receptor. Prog Hemost Thromb 9 (1989) 117-156
27. Stubbs M.T., and Bode W. A player of many parts: the spotlight falls on thrombin's structure. Thromb Res 69 (1993) 1-58
28. Gandossi E., Lunven C., and Berry C.N. Role of clotassociated thrombin in cell proliferation induced by fibrin clots in vitro. Br J Pharmacol 129 (2000) 1021-1027
29. Jin Y.R., Ryu C.K., Moon C.K., Cho M.R., and Yun Y.P. Inhibitory effects of J78, a newly synthesized 1,4-naphthoquinone derivative, on experimental thrombosis and platelet aggregation. Pharmacology 70 (2004) 195-200
30. Umetsu T., and Sanai K. Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats. Thromb Haemost 39 (1978) 74-83
31. Osende J.I., Shimbo D., Fuster V., Dubar M., and Badimon J.J. Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist. J Thromb Haemost 2 (2004) 492-498
32. Yoshioka M., and Tamada T. Aromatic factors of anti-platelet aggregation in fennel oil. Biogenic Amines 19 (2005) 89-96